Pediatrix Medical Group, Inc. (MD)
(Delayed Data from NYSE)
$9.02 USD
-0.02 (-0.22%)
Updated Apr 29, 2024 04:00 PM ET
After-Market: $9.02 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth C Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
MD 9.02 -0.02(-0.22%)
Will MD be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for MD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MD
ICON (ICLR) Up 7.6% Since Last Earnings Report: Can It Continue?
Pediatrix Medical Group, Inc. (MD) Up 11% Since Last Earnings Report: Can It Continue?
MD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Pediatrix's (MD) Q4 Earnings Miss Due to Soft Patient Volumes
Pediatrix Medical Group (MD) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
Will High Expenses Ail Pediatrix Medical's (MD) Q4 Earnings?
Other News for MD
Loyal Lithium Limited (ASX:LLI) - Trieste Lithium Takes Shape with More High Grade Intercepts
MD Crosses Above Average Analyst Target
Loyal Lithium Limited (ASX:LLI) Announces Significant Progress at Trieste Lithium Project with Exceptional Drill Results
Midland Amends Its Lithium Option Agreement With Rio Tinto With the Addition of the Wookie Project
Midland Expands Lithium Deal with Rio Tinto